Renaissance Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.76M Buy
18,349
+4,259
+30% +$1.34M 0.22% 112
2025
Q1
$4.29M Buy
14,090
+2,567
+22% +$782K 0.19% 113
2024
Q4
$3.83M Buy
11,523
+1,168
+11% +$388K 0.16% 115
2024
Q3
$3.46M Buy
10,355
+56
+0.5% +$18.7K 0.14% 116
2024
Q2
$4.24M Sell
10,299
-712
-6% -$293K 0.17% 110
2024
Q1
$4.45M Buy
11,011
+2,025
+23% +$818K 0.17% 109
2023
Q4
$2.76M Sell
8,986
-563
-6% -$173K 0.11% 128
2023
Q3
$2.31M Buy
9,549
+113
+1% +$27.4K 0.11% 124
2023
Q2
$2.27M Buy
9,436
+534
+6% +$128K 0.1% 127
2023
Q1
$1.67M Buy
8,902
+574
+7% +$108K 0.08% 164
2022
Q4
$1.77M Buy
8,328
+125
+2% +$26.6K 0.09% 119
2022
Q3
$1.29M Buy
8,203
+266
+3% +$41.8K 0.07% 152
2022
Q2
$1.19M Buy
7,937
+392
+5% +$58.7K 0.06% 161
2022
Q1
$1.23M Buy
7,545
+388
+5% +$63.5K 0.06% 160
2021
Q4
$1.56M Buy
7,157
+310
+5% +$67.5K 0.06% 129
2021
Q3
$1.3M Sell
6,847
-96
-1% -$18.2K 0.06% 131
2021
Q2
$1.23M Sell
6,943
-1,170
-14% -$207K 0.05% 141
2021
Q1
$1.33M Buy
8,113
+262
+3% +$43K 0.06% 124
2020
Q4
$1.09M Buy
7,851
+38
+0.5% +$5.29K 0.05% 135
2020
Q3
$873K Buy
7,813
+38
+0.5% +$4.25K 0.04% 133
2020
Q2
$723K Sell
7,775
-68
-0.9% -$6.32K 0.03% 159
2020
Q1
$576K Sell
7,843
-1,343
-15% -$98.6K 0.03% 176
2019
Q4
$772K Buy
9,186
+3,440
+60% +$289K 0.03% 171
2019
Q3
$483K Sell
5,746
-3,113
-35% -$262K 0.02% 203
2019
Q2
$580K Buy
+8,859
New +$580K 0.02% 182